Abstract
Each year, approximately 16,000 women become living kidney donors worldwide, donating a kidney to a spouse, family member, or friend. A common concern of women with childbearing potential is whether donation will affect future pregnancy outcomes. The first studies to examine pregnancy outcomes after living kidney donation were mostly reassuring; however, the two largest reported an increased risk of gestational hypertension and preeclampsia in groups of women with pregnancies after donation compared with groups of women with pregnancies before donation. A concern for donation-related risk was recently confirmed in an 11-year cohort study of 85 female donors and 510 healthy non-donors who were carefully matched on baseline risk factors. Donors were 2.4 times more likely to be diagnosed with gestational hypertension or preeclampsia (95 % CI 1.2 to 5.0) compared with healthy non-donors (the combined incidence was 11.5 vs. 4.8 %, respectively). Most donor pregnancies, however, were uncomplicated, with no increased risk for pre-term birth, low birth weight, or Caesarian section and no maternal or neonatal deaths. Importantly, black women were not represented in the three major studies to date, and future research should examine whether risk differs across donor subgroups. As well, a better understanding is needed of the clinical sequelae of gestational hypertension and preeclampsia, including long-term renal outcomes. Based on current evidence, we believe that potential donors with reproductive potential should be counseled on the possibility of a greater likelihood of gestational hypertension or preeclampsia if they choose to donate a kidney, with knowledge that the probability of the most serious outcomes (stillbirth, neonatal death, maternal death) is extremely low.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341:1725–30.
Evans RW, Manninen DL, Garrison LP, Hart LG, Blagg CR, Gutman RA, et al. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985;312:553–9.
Roberts SD, Maxwell DR, Gross TL. Cost-effective care of end-stage renal disease: a billion dollar question. Ann Intern Med. 1980;92:243–8.
Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M. Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives. Am J Transplant. 2004;4:569–73.
Reese PP, Boudville N, Garg AX. Living kidney donation: outcomes, ethics, and uncertainty. Lancet. 2015;385:2003–13.
Horvat LD, Shariff SZ, Garg AX. Global trends in the rates of living kidney donation. Kidney Int. 2009;75:1088–98.
Reese PP, Bloom RD, Feldman HI, Rosenbaum P, Wang W, Saynisch P, et al. Mortality and cardiovascular disease among older live kidney donors. Am J Transplant. 2014;14:1853–61.
Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303:959–66.
Garg AX, Meirambayeva A, Huang A, Kim J, Prasad GVR, Knoll G, et al. Cardiovascular disease in kidney donors: matched cohort study. BMJ. 2012;344:e1203.
Garg AX, Muirhead N, Knoll G, Yang RC, Prasad GVR, Thiessen-Philbrook H, et al. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int. 2006;70:1801–10.
Boudville N, Prasad GVR, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006;145:185–96.
Tong A, Chapman JR, Wong G, Kanellis J, McCarthy G, Craig JC. The motivations and experiences of living kidney donors: a thematic synthesis. Am J Kidney Dis. 2012;60:15–26.
Schutte JM, Steegers EAP, Schuitemaker NWE, Santema JG, de Boer K, Pel M, et al. Rise in maternal mortality in the Netherlands. BJOG. 2010;117:399–406.
Rochat RW, Koonin LM, Atrash HK, Jewett JF. Maternal mortality in the United States: report from the maternal mortality collaborative. Obstet Gynecol. 1988;72:91–7.
Ngoc NTN, Merialdi M, Abdel-Aleem H, Carroli G, Purwar M, Zavaleta N, et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ. 2006;84:699–705. World Health Organization.
American College of Obstetricians and Gynecologists (ACOG) Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99:159–67. Number 33, January 2002.
Koopmans CM, Bijlenga D, Groen H, Vijgen SMC, Aarnoudse JG, Bekedam DJ, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979–88.
Hladunewich MA, Kim SJ. Kidney donation: what might it mean for women wishing to become pregnant. Am J Kidney Dis. 2015;66(3):386–8.
Guidi E, Cozzi M, Milani S, Spada E. Nephrectomy modifies renal angiotensin II effects in kidney donors. Am J Hypertens. 2008;21:592–8.
Conrad KP, Gandley RE, Ogawa T, Nakanishi S, Danielson LA. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. Am J Physiol Ren Physiol. 1999;276:F767–76.
Lindheimer MD, Davison JM, Katz AI. The kidney and hypertension in pregnancy: twenty exciting years. Semin Nephrol. 2001;21:173–89.
Gibson KJ, Thomson CL, Boyce AC, Karime BM, Lumbers ER. Effects of a reduction in maternal renal mass on pregnancy and cardiovascular and renal function of the pregnant ewe. Am J Physiol Ren Physiol. 2006;290:F1153–62.
Packham DK, Hewitson TD, Whitworth JA, Kincaid-Smith PS. Glomerulosclerosis and hyalinosis in rabbits. Pathology. 1992;24:164–9.
Delmonico F. A report of the Amsterdam forum on the care of the live kidney donor: data and medical guidelines. Transplantation. 2005;79:S53–66.
Nevis IF, Garg AX. Maternal and fetal outcomes after living kidney donation. Am J Kidney Dis. 2009;9:661–8.
Ibrahim HN, Akkina SK, Leister E, Gillingham K, Cordner G, Guo H, et al. Pregnancy outcomes after kidney donation. Am J Transplant. 2009;9:825–34.
Reisaeter AV, Røislien J, Henriksen T, Irgens LM, Hartmann A. Pregnancy and birth after kidney donation: the Norwegian experience. Am J Transplant. 2009;9:820–4.
Wrenshall LE, McHugh L, Felton P, Dunn DL, Matas AJ. Pregnancy after donor nephrectomy. Transplantation. 1996;62:1934–6.
Jones JW, Acton RD, Elick B, Granger DK, Matas AJ. Pregnancy following kidney donation. Transplant Proc. 1993;25:3082.
Buszta C, Steinmuller DR, Novick AC, Schreiber MJ, Cunningham R, Popowniak KL, et al. Pregnancy after donor nephrectomy. Transplantation. 1985;40:651–4.
Josephson MA. Transplantation: pregnancy after kidney donation: more questions than answers. Nat Rev Nephrol. 2009;5:495–7.
Nayak-Rao S. Pregnancy after kidney donation—placing things in perspective. Saudi J Kidney Dis Transpl. 2011;22:552–3.
Baillargeon J. Characteristics of the healthy worker effect. Occup Med. 2001;16:359–66.
Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tydén G, Groth CG. Kidney donors live longer. Transplantation. 1997;64:976–8.
Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, et al. Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med. 2015;372:124. An 11-year cohort study of 85 female donors and 510 healthy non-donors (carefully matched on baseline risk). Donors were 2.4 times more likely to be diagnosed with gestational hypertension or preeclampsia than non-donors.
Hays RE. Informed consent of living kidney donors: pitfalls and best practice. Curr Transpl Rep. 2015;2:29–34.
O’Brien TE, Ray JG, Chan W-S. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14:368–74.
Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol. 2005;15:475–82.
Muzaale AD, Massie AB, Wang M-C, Montgomery RA, McBride MA, Wainright JL, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311:579–86.
Lentine KL, Schnitzler MA, Xiao H, Axelrod D, Garg AX, Tuttle-Newhall JE, et al. Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation. 2014;97:316–24.
Lentine KL, Schnitzler MA, Xiao H, Saab G, Salvalaggio PR, Axelrod D, et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med. 2010;363:724–32.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Amit Garg reports grants from Astellas and Roche. Jessica Sontrop has no relevant disclosures.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Live Kidney Donation
Rights and permissions
About this article
Cite this article
Sontrop, J.M., Garg, A.X. Considerations for Living Kidney Donation Among Women of Childbearing Age: Evidence from Recent Studies. Curr Transpl Rep 3, 10–14 (2016). https://doi.org/10.1007/s40472-016-0082-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40472-016-0082-0